š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this study is to evaluate the possibility that giving an inc...
Status
Completed
Location
Emory Children's Center - Pediatric Infectious Diseases
Start Date
2010-10
Trial ID
NCT01164553
Treatments Being Tested
This study is evaluating the safety and immunogenicity of GSK Biologicals' ...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08-01
Trial ID
NCT00129129
To describe any degree of preference for the route of administration of Flu...
Status
Completed
Location
Multiple Locations
Start Date
2008-01
Trial ID
NCT00623181
Treatments Being Tested
This study is designed to assess the immunogenicity and safety of the 2010-...
Status
Completed
Location
Multiple Locations
Start Date
2010-10
Trial ID
NCT01215669
The purpose of this research study is to find out if giving the smaller dos...
Status
Completed
Location
Saint Louis University
Start Date
2005-11
Trial ID
NCT00253734
Treatments Being Tested
This is one project of a larger ongoing study related to the immune system'...
Status
Completed
Location
Stanford University School of Medicine
Start Date
2019-10-08
Trial ID
NCT03898986
Treatments Being Tested
The main purpose of this Phase II study was to assess the safety and immuno...
Status
Completed
Location
Investigational Site Number :8400003
Start Date
2021-07-16
Trial ID
NCT04969276
Treatments Being Tested
The aim of the study is to evaluate the safety and immunogenicity of the 20...
Status
Completed
Location
Multiple Locations
Start Date
2015-09
Trial ID
NCT02563093
The purpose of this study is to investigate the responses to licensed triva...
Status
Completed
Location
Stanford LPCH Vaccine Program
Start Date
2011-08
Trial ID
NCT02141581
Treatments Being Tested
The purpose of this study is to generate additional data on the immunogenic...
Status
Completed
Location
Multiple Locations
Start Date
2009-09
Trial ID
NCT01011049